Literature DB >> 20595403

Postprandial plasma bile acid responses in normal weight and obese subjects.

C Glicksman1, D J Pournaras, M Wright, R Roberts, D Mahon, R Welbourn, R Sherwood, J Alaghband-Zadeh, C W le Roux.   

Abstract

BACKGROUND: Bile acids can act as signalling molecules via various receptors including the nuclear farnesoid X receptor (FXR) and pregnane X receptor (PXR), and the cell surface G-protein-coupled receptor TGR5. The signalling has been implicated in the release of peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), which improves glycaemic control and energy expenditure. We investigated whether morbidly obese subjects have altered postprandial bile acid responses in comparison to normal weight subjects.
METHOD: Blood samples were taken every 30 min from 0 to 180 min following a 400 kcal test meal. Samples were taken from 12 normal weight subjects with a body mass index (BMI) of 23.2 (2.8) kg/m(2) (median [interquartile range (IQR)]) and seven obese patients with a BMI of 47.2 (7.2) kg/m(2). Fractionated bile acids were measured on these samples using high-performance liquid chromatography tandem mass spectrometry.
RESULTS: The obese subjects showed a lower postprandial response in total bile acids compared with the normal weight subjects. An increase of 6.4 (5.0) and 2.6 (3.3) micromol/L (median [IQR]) in normal weight and obese subjects was observed, respectively (P = 0.02). The difference was predominantly due to the glycine-conjugated fraction (P = 0.03). There was no difference in the increase of the unconjugated or taurine-conjugated fractions.
CONCLUSIONS: The decreased postprandial bile acid response in obese subjects compared with normal weight subjects may partly explain the suboptimal GLP-1 and PYY responses and could affect appetite, glycaemic control and energy expenditure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595403     DOI: 10.1258/acb.2010.010040

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  37 in total

1.  Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Authors:  Mitsuhiro Watanabe; Yasushi Horai; Sander M Houten; Kohkichi Morimoto; Taichi Sugizaki; Eri Arita; Chikage Mataki; Hiroyuki Sato; Yusuke Tanigawara; Kristina Schoonjans; Hiroshi Itoh; Johan Auwerx
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 2.  Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.

Authors:  Mohsen Mazidi; Pedro Paulo P de Caravatto; John R Speakman; Ricardo V Cohen
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 3.  The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery.

Authors:  Farnaz Fouladi; James E Mitchell; Joseph A Wonderlich; Kristine J Steffen
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

Review 4.  Cholestatic liver (dys)function during sepsis and other critical illnesses.

Authors:  Marc Jenniskens; Lies Langouche; Yoo-Mee Vanwijngaerden; Dieter Mesotten; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2015-09-21       Impact factor: 17.440

5.  Systemic bile acids induce insulin resistance in a TGR5-independent manner.

Authors:  Kristen E Syring; Travis J Cyphert; Thomas C Beck; Charles R Flynn; Nicholas A Mignemi; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-19       Impact factor: 4.310

Review 6.  Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery.

Authors:  Steven K Malin; Sangeeta R Kashyap
Journal:  Curr Obes Rep       Date:  2015-06

Review 7.  Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.

Authors:  J Grams; W Timothy Garvey
Journal:  Curr Obes Rep       Date:  2015-06

8.  Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.

Authors:  C Ullmer; R Alvarez Sanchez; U Sprecher; S Raab; P Mattei; H Dehmlow; S Sewing; A Iglesias; J Beauchamp; K Conde-Knape
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.

Authors:  Wilson Salgado Júnior; Carlos Augusto de Mattos Donadelli; José Sebastião Dos Santos; Carla Barbosa Nonino
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

Review 10.  The Influence of Bariatric Surgery on Serum Bile Acids in Humans and Potential Metabolic and Hormonal Implications: a Systematic Review.

Authors:  Abigail J Cole; Levi M Teigen; Cyrus Jahansouz; Carrie P Earthman; Shalamar D Sibley
Journal:  Curr Obes Rep       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.